Wells Fargo
ETON icon

Wells Fargo’s Eton Pharmaceutcials ETON Stock Holding History

Wells Fargo’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.15M Buy
114,655
+105,096
+1,099% +$3.08M ﹤0.01% 3019
2026
Q1 		$236K Sell
9,559
-18,734
-66% -$328K ﹤0.01% 4612
2025
Q4 		$478K Buy
28,293
+11,584
+69% +$204K ﹤0.01% 4529
2025
Q3 		$363K Buy
16,709
+2,959
+22% +$49.1K ﹤0.01% 4530
2025
Q2 		$196K Buy
13,750
+13,000
+1,733% +$206K ﹤0.01% 4786
2025
Q1 		$9.73K Sell
750
-250
-25% -$3.78K ﹤0.01% 5888
2024
Q4 		$13.3K Buy
+1,000
New +$10.1K ﹤0.01% 5868
2024
Q2 		– Sell
-1,425
Closed -$5.34K – 7063
2024
Q1 		$5.34K Buy
1,425
+1,253
+728% +$5.47K ﹤0.01% 5884
2023
Q4 		$753 Buy
172
+9
+6% +$36 ﹤0.01% 6294
2023
Q3 		$680 Buy
163
+11
+7% +$42 ﹤0.01% 6293
2023
Q2 		$530 Buy
152
+7
+5% +$26 ﹤0.01% 6475
2023
Q1 		$558 Sell
145
-3,998
-97% -$14.6K ﹤0.01% 6527
2022
Q4 		$11.7K Buy
4,143
+4
+0.1% +$11 ﹤0.01% 5486
2022
Q3 		$9K Buy
4,139
+1
+0% +$2 ﹤0.01% 5718
2022
Q2 		$11K Sell
4,138
-3,486
-46% -$11.7K ﹤0.01% 5703
2022
Q1 		$34K Buy
7,624
+7,500
+6,048% +$29.5K ﹤0.01% 5811
2021
Q4 		$1K Buy
124
+1
+0.8% +$5 ﹤0.01% 7000
2021
Q3 		$1K Sell
123
-316
-72% -$1.64K ﹤0.01% 6695
2021
Q2 		$3K Sell
439
-15,912
-97% -$118K ﹤0.01% 6456
2021
Q1 		$120K Sell
16,351
-9,718
-37% -$82.9K ﹤0.01% 5401
2020
Q4 		$212K Buy
26,069
+5,548
+27% +$42.8K ﹤0.01% 5057
2020
Q3 		$162K Sell
20,521
-8,592
-30% -$58.7K ﹤0.01% 5058
2020
Q2 		$158K Buy
29,113
+26,040
+847% +$129K ﹤0.01% 5025
2020
Q1 		$12K Sell
3,073
-2,927
-49% -$17.1K ﹤0.01% 5715
2019
Q4 		$43K Hold
6,000
– – ﹤0.01% 5553
2019
Q3 		$38K Hold
6,000
– – ﹤0.01% 5636
2019
Q2 		$47K Hold
6,000
– – ﹤0.01% 5574
2019
Q1 		$48K Hold
6,000
– – ﹤0.01% 5331
2018
Q4 		$37K Buy
+6,000
New +$36.8K ﹤0.01% 5615

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

Wells Fargo's ETON Position: Q2 2026 in Review

Wells Fargo increased its Eton Pharmaceutcials (ETON) stake by 1,099% in Q2 2026, buying an estimated $3.08M and bringing the position to 114,655 shares worth $4.15M. The position accounts for ﹤0.01% of the portfolio, ranked #3019.

Wells Fargo first reported a position in ETON in Q4 2018 and has held it in 29 quarters since. 164 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Wells Fargo held 114,655 shares of Eton Pharmaceutcials worth $4.15M as of Q2 2026.
  • Wells Fargo bought 105,096 Eton Pharmaceutcials shares in Q2 2026, an estimated $3.08M.
  • Eton Pharmaceutcials made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #3019 holding.
  • Wells Fargo first reported a position in Eton Pharmaceutcials in Q4 2018 and has held it in 29 quarters since.
  • 164 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.